AMRX - Company ID 0001723128
The table below shows Amneal Pharmaceuticals, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $127.64M | $197.66M | $201.25M | $71.54M | $59.19M | $74.01M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $677.95M | $641.62M | $614.50M | $608.97M | $601.43M | $596.36M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.95B |
| $1.80B |
| $1.84B |
| $1.58B |
| $1.51B |
| $1.51B |
| Property, plant & equipment | $456.88M | $444.61M | $434.99M | $440.33M | $427.23M | $431.02M |
| Goodwill | $593.50M | $593.80M | $595.95M | $597.41M | $597.50M | $598.32M |
| Total assets | $3.78B | $3.54B | $3.60B | $3.42B | $3.37B | $3.46B |
| Accounts payable | - | - | $266.36M | $205.81M | $192.53M | $235.00M |
| Total current liabilities | $883.19M | $728.05M | $862.11M | $1.11B | $1.08B | $1.10B |
| Long-term debt | $2.56B | $2.57B | $2.57B | $2.15B | $2.15B | $2.17B |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$415.09M | -$472.75M | -$570.08M | -$572.45M | -$594.87M | -$575.98M |
| Total equity | $33.02M | -$45.41M | -$109.46M | -$112.12M | -$131.67M | -$93.43M |